Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 16.29
(-0.12%)
CNY 16.29
(-0.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.2 Billion CNY | 216.32% |
| 2022 | -1.03 Billion CNY | -3364.3% |
| 2021 | 31.64 Million CNY | 102.97% |
| 2020 | -1.06 Billion CNY | -56.11% |
| 2019 | -683.35 Million CNY | 12.08% |
| 2018 | -777.26 Million CNY | 3.17% |
| 2017 | -802.67 Million CNY | -84.92% |
| 2016 | -434.05 Million CNY | -14.05% |
| 2015 | -380.58 Million CNY | 5.22% |
| 2014 | -401.53 Million CNY | 43.42% |
| 2013 | -709.63 Million CNY | 51.13% |
| 2012 | -1.45 Billion CNY | 15.31% |
| 2011 | -1.71 Billion CNY | -769.9% |
| 2010 | -197.09 Million CNY | 6.52% |
| 2009 | -210.83 Million CNY | -119.32% |
| 2008 | -96.13 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 955.65 Million CNY | 38.47% |
| 2024 Q2 | 690.17 Million CNY | -29.85% |
| 2024 Q1 | 983.9 Million CNY | -18.1% |
| 2023 FY | 1.2 Billion CNY | 216.32% |
| 2023 Q2 | -435.86 Million CNY | -1380.13% |
| 2023 Q4 | 1.2 Billion CNY | 120.29% |
| 2023 Q3 | 545.35 Million CNY | 225.12% |
| 2023 Q1 | 34.04 Million CNY | 103.3% |
| 2022 Q3 | -994.91 Million CNY | 5.73% |
| 2022 Q1 | -373.23 Million CNY | -1279.62% |
| 2022 Q4 | -1.03 Billion CNY | -3.81% |
| 2022 Q2 | -1.05 Billion CNY | -182.78% |
| 2022 FY | -1.03 Billion CNY | -3364.3% |
| 2021 Q3 | -23.53 Million CNY | 97.7% |
| 2021 FY | 31.64 Million CNY | 102.97% |
| 2021 Q1 | -873.53 Million CNY | 18.12% |
| 2021 Q2 | -1.02 Billion CNY | -17.31% |
| 2021 Q4 | 31.64 Million CNY | 234.46% |
| 2020 FY | -1.06 Billion CNY | -56.11% |
| 2020 Q4 | -1.06 Billion CNY | 10.82% |
| 2020 Q1 | -1.1 Billion CNY | -61.36% |
| 2020 Q2 | -1.09 Billion CNY | 0.81% |
| 2020 Q3 | -1.19 Billion CNY | -9.37% |
| 2019 Q3 | -744.73 Million CNY | -36.11% |
| 2019 Q1 | -846.53 Million CNY | -8.91% |
| 2019 FY | -683.35 Million CNY | 12.08% |
| 2019 Q4 | -683.35 Million CNY | 8.24% |
| 2019 Q2 | -547.15 Million CNY | 35.37% |
| 2018 FY | -777.26 Million CNY | 3.17% |
| 2018 Q4 | -777.26 Million CNY | 21.99% |
| 2018 Q3 | -996.33 Million CNY | 26.11% |
| 2018 Q2 | -1.34 Billion CNY | -92.32% |
| 2018 Q1 | -701.07 Million CNY | 12.66% |
| 2017 Q2 | -846.77 Million CNY | 46.92% |
| 2017 Q1 | -1.59 Billion CNY | -267.55% |
| 2017 Q4 | -802.67 Million CNY | 9.72% |
| 2017 FY | -802.67 Million CNY | -84.92% |
| 2017 Q3 | -889.09 Million CNY | -5.0% |
| 2016 Q2 | -367.01 Million CNY | -8.42% |
| 2016 Q3 | -269.4 Million CNY | 26.6% |
| 2016 Q4 | -434.05 Million CNY | -61.12% |
| 2016 FY | -434.05 Million CNY | -14.05% |
| 2016 Q1 | -338.5 Million CNY | 11.06% |
| 2015 Q3 | -235.12 Million CNY | 35.91% |
| 2015 FY | -380.58 Million CNY | 5.22% |
| 2015 Q2 | -366.86 Million CNY | 20.38% |
| 2015 Q1 | -460.78 Million CNY | -14.76% |
| 2015 Q4 | -380.58 Million CNY | -61.87% |
| 2014 Q3 | -708.96 Million CNY | 4.59% |
| 2014 FY | -401.53 Million CNY | 43.42% |
| 2014 Q4 | -401.53 Million CNY | 43.36% |
| 2014 Q2 | -743.04 Million CNY | -5.27% |
| 2014 Q1 | -705.83 Million CNY | 0.54% |
| 2013 Q4 | -709.63 Million CNY | 29.41% |
| 2013 FY | -709.63 Million CNY | 51.13% |
| 2013 Q1 | -1.5 Billion CNY | -3.93% |
| 2013 Q2 | -1.17 Billion CNY | 22.35% |
| 2013 Q3 | -1 Billion CNY | 14.22% |
| 2012 Q4 | -1.45 Billion CNY | 1.35% |
| 2012 Q1 | -1.61 Billion CNY | 5.83% |
| 2012 Q2 | -1.53 Billion CNY | 4.92% |
| 2012 Q3 | -1.47 Billion CNY | 4.12% |
| 2012 FY | -1.45 Billion CNY | 15.31% |
| 2011 FY | -1.71 Billion CNY | -769.9% |
| 2011 Q2 | -44.01 Million CNY | 0.0% |
| 2011 Q3 | -1.94 Billion CNY | -4317.38% |
| 2011 Q4 | -1.71 Billion CNY | 11.81% |
| 2010 Q4 | -197.09 Million CNY | 0.0% |
| 2010 FY | -197.09 Million CNY | 6.52% |
| 2009 FY | -210.83 Million CNY | -119.32% |
| 2008 FY | -96.13 Million CNY | 0.0% |